ASCIA 2024 Conference Report
Congratulations to Dr Jovanka King (Chair) and her committee for organising a highly successful ASCIA 2024 Conference with an outstanding program. The conference attracted another record high number of 712 delegates including 518 in-person (73%) and 193 virtual (27%), in addition to staff and representatives from 36 sponsor/exhibitor organisations.Â
This was a hybrid conference, which enables on-demand viewing of sessions for all registered delegates for 6 months after the conference. Read more hereÂ
ASCIA Annual General Meeting 2024
A total of 117 ASCIA members (81 in-person and 36 online) attended the ASCIA Annual General Meeting (AGM) which was held on Thursday 5 September 2024, at the Adelaide Convention Centre.
Welcome to the new ASCIA President Dr Michael O’Sullivan, and thank you to the outgoing President, A/Prof Theresa Cole for providing excellent leadership over the past two years.
The ASCIA AGM 2024 Minutes are available here
Current ASCIA Council members are listed hereÂ
Health Professional Allergy Education and Training Initiatives
ASCIA is facilitating education and training initiatives to upskill health professionals, as part of the National Allergy Council Shared Care for Allergy project, funded by the Australian Government.
The aim is to improve access to quality allergy education and training for health professionals.
Congratulations to the successful applicants of the five initiatives selected for funding in the 2024 call for Expressions of Interests from ASCIA members. Read more hereÂ
Recent ASCIA Anaphylaxis and Allergy Updates
ASCIA Oral Immunotherapy (OIT) for Food Allergy Frequently Asked Questions (FAQ) for patients and carers - updated to add statements about impact on daily life and factors that can increase the risk of allergic reactions, including anaphylaxis. Read more here
New ASCIA Anaphylaxis Refresher Training video – developed to provide accessible and hands-free training that takes around 16 minutes to watch. Feedback is welcome by mid October 2024 as we plan to make minor updates at the end of next month.
New ASCIA Management Summary for Allergic Conditions - developed for health professionals to complete, to support continuity of care, including transition from paediatric to adult medical care.
ASCIA Anaphylaxis Checklist for Young Adults - updated to make it easier to read and to include a link to Allergy 250K for young adults.
How to position a person having anaphylaxis - updated to include new ASCIA infographic showing how to position a person when adrenaline is given.
ASCIA Quicklinks - developed to improve access to ASCIA website information using QR codes.
For other updates read more here
Shingrix Vaccine to Prevent Shingles - September 2024 Update
Shingrix® is a varicella zoster virus recombinant vaccine that can provide protection from herpes zoster (shingles) and post-herpetic neuralgia (long-term nerve pain).
Further to ASCIA advocating for funded access to Shingrix® for people with immune deficiencies on the national immunisation program in Australia, funding has been announced in September 2024.
Read more here
Other recent ASCIA Immunodeficiency and Autoimmunity UpdatesÂ
ASCIA 2025 Conference - Save the Date
The ASCIA 2025 Conference, chaired by Dr Alberto Pinzon-Charry, will be held at the Brisbane Convention and Exhibition Centre from Tuesday 2nd to Friday 5th September 2025.
This will be a hybrid conference, which enables virtual registration for delegates who cannot attend in-person, and on-demand viewing of sessions for all registered delegates for 6 months after the conference. Read more here
Regularly Updated ASCIA Webpages
The following ASCIA webpages are regularly updated:
Referrals
ASCIA Reports
Locate a Specialist
ASCIA Submissions
Allergy/Immunology Positions
Allergy and Immunology Research
Conference, Meetings and Events Calendar
Â
ASCIA gratefully acknowledges the generous support of all sponsors listed on the ASCIA website www.allergy.org.au/about-ascia/sponsors
